PITTSBURGH, June 28,
2023 /PRNewswire/
-- Viatris Inc. (NASDAQ: VTRS) plans to report its
second quarter 2023 financial results on Monday, August 7 before the open of the U.S.
financial markets. Chief Executive Officer Scott A. Smith, President Rajiv Malik, and Chief Financial
Officer Sanjeev
Narula also will host a webcast at 8:30 a.m. ET on
August 7 to discuss the results.
Investors and the general public are invited to listen to a live
webcast of the call at investor.viatris.com or by calling
800-274-8461 or 203-518-9783 for international callers (Conference
ID: VTRSQ223). A replay of the webcast also will be available
on the website.
About Viatris
Viatris Inc. (NASDAQ: VTRS) is a
global healthcare company empowering people worldwide to live
healthier at every stage of life. We provide access to medicines,
advance sustainable operations, develop innovative solutions and
leverage our collective expertise to connect more people to more
products and services through our one-of-a-kind Global Healthcare
Gateway®. Formed in November 2020, Viatris brings together
scientific, manufacturing and distribution expertise with proven
regulatory, medical, and commercial capabilities to deliver
high-quality medicines to patients in more than 165 countries and
territories. Viatris' portfolio comprises more than 1,400 approved
molecules across a wide range of therapeutic areas, spanning both
non-communicable and infectious diseases, including globally
recognized brands, complex generic and branded medicines, and a
variety of over-the-counter consumer products. With more than
38,000 colleagues globally, Viatris is headquartered in the U.S.,
with global centers in Pittsburgh,
Shanghai and Hyderabad, India. Learn more
at viatris.com and investor.viatris.com, and connect
with us on Twitter, LinkedIn, Instagram and
YouTube.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/viatris-to-report-second-quarter-2023-financial-results-on-august-7-2023-301866013.html
SOURCE Viatris Inc.